↓ Skip to main content

Dove Medical Press

Article Metrics

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine

Overview of attention for article published in Drug Design, Development and Therapy, February 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

patent
4 patents

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
44 Mendeley
Title
Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
Published in
Drug Design, Development and Therapy, February 2011
DOI 10.2147/dddt.s5392
Pubmed ID
Authors

Russell Cohen, Oliveira

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Pakistan 1 2%
Czechia 1 2%
Unknown 40 91%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 23%
Student > Ph. D. Student 7 16%
Researcher 6 14%
Student > Postgraduate 4 9%
Other 4 9%
Other 10 23%
Unknown 3 7%
Readers by discipline Count As %
Medicine and Dentistry 19 43%
Pharmacology, Toxicology and Pharmaceutical Science 7 16%
Psychology 3 7%
Immunology and Microbiology 2 5%
Agricultural and Biological Sciences 2 5%
Other 6 14%
Unknown 5 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2015.
All research outputs
#2,928,646
of 10,930,087 outputs
Outputs from Drug Design, Development and Therapy
#190
of 1,167 outputs
Outputs of similar age
#90,712
of 259,691 outputs
Outputs of similar age from Drug Design, Development and Therapy
#7
of 34 outputs
Altmetric has tracked 10,930,087 research outputs across all sources so far. This one has received more attention than most of these and is in the 51st percentile.
So far Altmetric has tracked 1,167 research outputs from this source. They receive a mean Attention Score of 3.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,691 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.